West Pharmaceutical Services WST Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by West Pharmaceutical Services in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: West Pharmaceutical Services’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about West Pharmaceutical Services's other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is West Pharmaceutical Services's other income, net (note 6)?
- West Pharmaceutical Services (WST) reported other income, net (note 6) of -$200K in Q1 2026.
- How has West Pharmaceutical Services's other income, net (note 6) changed year-over-year?
- West Pharmaceutical Services's other income, net (note 6) decreased by 0.0% year-over-year, from -$200K to -$200K.
- What is the long-term trend for West Pharmaceutical Services's other income, net (note 6)?
- Over 3 years (2021 to 2025), West Pharmaceutical Services's other income, net (note 6) has grown at a -35.9% compound annual growth rate (CAGR), from $3.8M to -$1M.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.